148 related articles for article (PubMed ID: 37036241)
1. Comparing quality of life in women with vulvovaginal lichen planus treated with topical and systemic treatments using the vulvar quality of life index.
Kherlopian A; Fischer G
Australas J Dermatol; 2023 May; 64(2):e125-e134. PubMed ID: 37036241
[TBL] [Abstract][Full Text] [Related]
2. Quality of life impact and treatment response in vulval disease: Comparison of 3 common conditions using the Vulval Quality of Life Index.
Wu M; Kherlopian A; Wijaya M; Fischer G
Australas J Dermatol; 2022 Nov; 63(4):e320-e328. PubMed ID: 35932464
[TBL] [Abstract][Full Text] [Related]
3. Identifying predictors of systemic immunosuppressive treatment of vulvovaginal lichen planus: A retrospective cohort study of 122 women.
Kherlopian A; Fischer G
Australas J Dermatol; 2022 Aug; 63(3):335-343. PubMed ID: 35500127
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of vulvovaginal lichen planus with tildrakizumab: A case series of 24 patients.
Kherlopian A; Fischer G
Australas J Dermatol; 2022 May; 63(2):251-255. PubMed ID: 35099060
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of deucravacitinib compared to methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids: a study protocol for a single-centre double-blinded randomised controlled trial.
Wijaya M; Fischer G; Saunderson RB
Trials; 2024 Mar; 25(1):181. PubMed ID: 38475894
[TBL] [Abstract][Full Text] [Related]
6. Erosive vulvar lichen planus: retrospective review of characteristics and outcomes in 113 patients seen in a vulvar specialty clinic.
Kennedy CM; Galask RP
J Reprod Med; 2007 Jan; 52(1):43-7. PubMed ID: 17286068
[TBL] [Abstract][Full Text] [Related]
7. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus.
Byrd JA; Davis MD; Rogers RS
Arch Dermatol; 2004 Jun; 140(6):715-20. PubMed ID: 15210463
[TBL] [Abstract][Full Text] [Related]
8. Management of vulvovaginal lichen planus: a new approach.
Bradford J; Fischer G
J Low Genit Tract Dis; 2013 Jan; 17(1):28-32. PubMed ID: 23222048
[TBL] [Abstract][Full Text] [Related]
9. Patient satisfaction after the treatment of vulvovaginal erosive lichen planus with topical clobetasol and tacrolimus: a survey study.
Jensen JT; Bird M; Leclair CM
Am J Obstet Gynecol; 2004 Jun; 190(6):1759-63; discussion 1763-5. PubMed ID: 15284791
[TBL] [Abstract][Full Text] [Related]
10. Unwarranted hysterectomy in a case of oro-vaginal-vulvar lichen planus in a young woman: a case report.
Goyal LD; Garg P; Kaur M
J Med Case Rep; 2021 Feb; 15(1):97. PubMed ID: 33632292
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study.
Boch K; Langan EA; Zillikens D; Ludwig RJ; Kridin K
J Dermatol; 2021 Dec; 48(12):1913-1917. PubMed ID: 34668211
[TBL] [Abstract][Full Text] [Related]
12. The Vulval Disease Quality of Life Index in women with vulval lichen sclerosus correlates with clinician and symptom scores.
Felmingham C; Chan L; Doyle LW; Veysey E
Australas J Dermatol; 2020 May; 61(2):110-118. PubMed ID: 31729009
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life in Vulvar Lichen Sclerosus Patients Treated With Long-Term Topical Corticosteroids.
Wijaya M; Lee G; Fischer G; Lee A
J Low Genit Tract Dis; 2021 Apr; 25(2):158-165. PubMed ID: 33746196
[TBL] [Abstract][Full Text] [Related]
14. Quality of life of women with untreated vulval lichen sclerosus assessed with vulval quality of life index (VQLI).
Wijaya M; Lee G; Fischer G
Australas J Dermatol; 2021 May; 62(2):177-182. PubMed ID: 33508152
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapy for vulval Erosive Lichen Planus (the 'hELP' trial): study protocol for a randomised controlled trial.
Simpson RC; Murphy R; Bratton DJ; Sydes MR; Wilkes S; Nankervis H; Dowey S; Thomas KS
Trials; 2016 Jan; 17():2. PubMed ID: 26729245
[TBL] [Abstract][Full Text] [Related]
16. Lichen planus affecting the female genitalia: A retrospective review of patients at Mayo Clinic.
Fahy CMR; Torgerson RR; Davis MDP
J Am Acad Dermatol; 2017 Dec; 77(6):1053-1059. PubMed ID: 29031660
[TBL] [Abstract][Full Text] [Related]
17. Disease remission of refractory vulvovaginal and gingival lichen planus with tildrakizumab.
Kherlopian A; Fischer G
Australas J Dermatol; 2021 May; 62(2):246-247. PubMed ID: 33742446
[No Abstract] [Full Text] [Related]
18. Erosive lichen planus of the vulva and vagina.
Lotery HE; Galask RP
Obstet Gynecol; 2003 May; 101(5 Pt 2):1121-5. PubMed ID: 12738123
[TBL] [Abstract][Full Text] [Related]
19. Why do some patients with vulval lichen sclerosus on long-term topical corticosteroid treatment experience ongoing poor quality of life?
Wijaya M; Lee G; Fischer G
Australas J Dermatol; 2022 Nov; 63(4):463-472. PubMed ID: 36208206
[TBL] [Abstract][Full Text] [Related]
20. Vulvar quality of life index (VQLI) - A simple tool to measure quality of life in patients with vulvar disease.
Saunderson RB; Harris V; Yeh R; Mallitt KA; Fischer G
Australas J Dermatol; 2020 May; 61(2):152-157. PubMed ID: 31984477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
